Conversely, the low-risk group exhibited enrichment in the following top five pathways: endocytosis, insulin signaling pathway, neurotrophin signaling pathway, pathways in cancer, and valine leucine and isoleucine degradation (Fig. 6D). This evidence concerns the gene BDNF and cancer.